Comparison of Coronary Artery Bypass Surgery With Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease
Michael S. Lee, MD,
Nikhil Kapoor, MD,
Faizi Jamal, MD,
Lawrence Czer, MD,
Joseph Aragon, MD,
James Forrester, MD,
Saibal Kar, MD,
Suhail Dohad, MD,
Robert Kass, MD,
Neal Eigler, MD,
Alfredo Trento, MD,
Prediman K. Shah, MD and
Raj R. Makkar, MD*
Cedars-Sinai Medical Center, University of California, Los Angeles School of Medicine, Los Angeles, California
View larger version (14K):
[in a new window]
|
Figure 1 Major adverse cardiac and cerebrovascular events (including death, myocardial infarction, cerebrovascular events, and target vessel revascularization) (MACCE)-free survival (A). Freedom from death (the second death in the percutaneous coronary intervention [PCI] group was in a patient with a Parsonnet score of 23 who was a "do not resuscitate/do not intubate" patient who died after developing acute pulmonary edema after an outpatient blood transfusion) (B). Freedom from target vessel revascularization (all three patients who underwent repeat PCI had distal bifurcation involvement; two patients had focal in-stent restenosis at the ostium of the left circumflex artery, and one patient had focal in-stent restenosis at the ostium of the left anterior descending artery) (C). Freedom from death, myocardial infarction, and cerebrovascular events (D). CABG = coronary artery bypass graft.
|
|
|
